Suppr超能文献

基于对流-扩散方程的连续肠道吸收模型。

Continuous Intestinal Absorption Model Based on the Convection-Diffusion Equation.

机构信息

Department of Pharmaceutical Sciences, Temple University School of Pharmacy , Philadelphia, Pennsylvania 19140, United States.

Department of Physics, University of Texas , Austin, Texas 78712, United States.

出版信息

Mol Pharm. 2017 Sep 5;14(9):3069-3086. doi: 10.1021/acs.molpharmaceut.7b00286. Epub 2017 Jul 31.

Abstract

Prediction of the rate and extent of drug absorption upon oral dosing needs models that capture the complexities of both the drug molecule and intestinal physiology. We report here the development of a continuous intestinal absorption model based on the convection-diffusion equation. The model includes explicit enterocyte apical membrane and intracellular lipid radial compartments along the length of the intestine. Physiologic functions along length x are built into the model and include velocity, diffusion, surface areas, and pH of the intestine. Also included are expression levels of the intestinal active uptake transporter OATP2B1 and efflux transporter P-gp. Oral dosing of solution as well as solid (with a dissolution function) was modeled for several drugs. The fraction absorbed (FA) and concentration-time (C-t) profiles were predicted and compared with clinical data. Overall, FA was well predicted upon oral (n = 21) or colonic dosing (n = 11), with four outliers. The overall accuracy (prediction of the correct bin) was 81% with outliers and 90% without outliers. Of the nine solution dosing data sets, six drugs were very well predicted with an exposure overlap coefficient (EOC) > 0.9 and predicted C and T values similar to those observed. Of the six solid dose formulations evaluated, the EOC values were > 0.9 for all drugs except budesonide. The observed precipitation of nifedipine at high doses was predicted by the model. Most of the poor predictions were for drugs that are known to be transporter substrates. As proof of concept, incorporating OATP2B1 and P-gp markedly improved the EOC and predicted C and T for fexofenadine. Finally, the continuous intestinal model accurately recapitulated the known relationships between drug absorption and permeability, solubility, and particle size. Together, these results indicate that this preliminary intestinal absorption model offers a simple and straightforward framework to build in complexities such as drug permeability, lipid partitioning, solubility, metabolism, and transport for improved prediction of the rate and extent of drug absorption.

摘要

口服给药时药物吸收的速度和程度需要能够捕捉药物分子和肠道生理学复杂性的模型。我们在此报告了一种基于对流-扩散方程的连续肠道吸收模型的开发。该模型包括沿肠道长度的明确的肠细胞顶膜和细胞内脂质径向隔室。生理功能沿着 x 长度构建到模型中,包括肠道的速度、扩散、表面积和 pH。还包括肠道主动摄取转运体 OATP2B1 和外排转运体 P-gp 的表达水平。对几种药物进行了溶液和固体(带有溶解功能)的口服给药建模。预测了吸收分数(FA)和浓度-时间(C-t)曲线,并将其与临床数据进行比较。总体而言,口服(n=21)或结肠给药(n=11)的 FA 得到了很好的预测,有四个离群值。有离群值时的总体准确性(正确分类的预测)为 81%,无离群值时为 90%。在 9 个溶液给药数据集,有 6 种药物的预测非常好,暴露重叠系数(EOC)>0.9,预测的 C 和 T 值与观察值相似。在评估的 6 种固体剂量配方中,除了布地奈德外,所有药物的 EOC 值都>0.9。模型预测了硝苯地平在高剂量下的沉淀。大多数预测不佳的药物是已知的转运体底物。作为概念验证,纳入 OATP2B1 和 P-gp 显著提高了依匹斯汀的 EOC 以及预测的 C 和 T。最后,连续肠道模型准确地再现了药物吸收与通透性、溶解度和粒径之间的已知关系。这些结果表明,这种初步的肠道吸收模型为提高药物吸收速度和程度的预测提供了一个简单而直接的框架,可以构建药物通透性、脂质分配、溶解度、代谢和转运等复杂性。

相似文献

1
Continuous Intestinal Absorption Model Based on the Convection-Diffusion Equation.
Mol Pharm. 2017 Sep 5;14(9):3069-3086. doi: 10.1021/acs.molpharmaceut.7b00286. Epub 2017 Jul 31.
4
Predicting Impact of Food and Feeding Time on Oral Absorption of Drugs with a Novel Rat Continuous Intestinal Absorption Model.
Drug Metab Dispos. 2022 Jun;50(6):750-761. doi: 10.1124/dmd.122.000831. Epub 2022 Mar 26.
5
Intestinal absorption mechanism of rotundic acid: Involvement of P-gp and OATP2B1.
J Ethnopharmacol. 2022 May 10;289:115006. doi: 10.1016/j.jep.2022.115006. Epub 2022 Jan 17.
7
Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting.
Am J Physiol Gastrointest Liver Physiol. 2009 Aug;297(2):G371-7. doi: 10.1152/ajpgi.00102.2009. Epub 2009 Jun 18.
10
Advantage of the Dissolution/Permeation System for Estimating Oral Absorption of Drug Candidates in the Drug Discovery Stage.
Mol Pharm. 2016 May 2;13(5):1564-74. doi: 10.1021/acs.molpharmaceut.6b00044. Epub 2016 Apr 13.

引用本文的文献

1
Mechanistic studies on pH-permeability relationships: Impact of the membrane polar headgroup region on pKa.
Int J Pharm. 2025 Mar 30;673:125383. doi: 10.1016/j.ijpharm.2025.125383. Epub 2025 Feb 22.
3
A Continuous Intestinal Absorption Model to Predict Drug Enterohepatic Recirculation in Healthy Humans: Nalbuphine as a Model Substrate.
Mol Pharm. 2024 Sep 2;21(9):4510-4523. doi: 10.1021/acs.molpharmaceut.4c00424. Epub 2024 Jul 2.
4
The Rat Continuous Intestine Model Predicts the Impact of Particle Size and Transporters on the Oral Absorption of Glyburide.
Mol Pharm. 2023 Jan 2;20(1):219-231. doi: 10.1021/acs.molpharmaceut.2c00597. Epub 2022 Dec 21.
5
IVIVE: Facilitating the Use of Toxicity Data in Risk Assessment and Decision Making.
Toxics. 2022 May 1;10(5):232. doi: 10.3390/toxics10050232.
6
A permeability- and perfusion-based PBPK model for improved prediction of concentration-time profiles.
Clin Transl Sci. 2022 Aug;15(8):2035-2052. doi: 10.1111/cts.13314. Epub 2022 May 31.
7
Predicting Impact of Food and Feeding Time on Oral Absorption of Drugs with a Novel Rat Continuous Intestinal Absorption Model.
Drug Metab Dispos. 2022 Jun;50(6):750-761. doi: 10.1124/dmd.122.000831. Epub 2022 Mar 26.
8
Prediction of Drug Clearance from Enzyme and Transporter Kinetics.
Methods Mol Biol. 2021;2342:369-417. doi: 10.1007/978-1-0716-1554-6_14.

本文引用的文献

1
Drug Distribution. Part 1. Models to Predict Membrane Partitioning.
Pharm Res. 2017 Mar;34(3):535-543. doi: 10.1007/s11095-016-2085-z. Epub 2016 Dec 15.
2
Intracellular Unbound Atorvastatin Concentrations in the Presence of Metabolism and Transport.
J Pharmacol Exp Ther. 2016 Oct;359(1):26-36. doi: 10.1124/jpet.116.235689. Epub 2016 Jul 22.
3
Gastrointestinal Motility, Part 2: Small-Bowel and Colon Transit.
J Nucl Med Technol. 2016 Mar;44(1):12-8. doi: 10.2967/jnumed.113.134551.
4
In Silico Modeling of Gastrointestinal Drug Absorption: Predictive Performance of Three Physiologically Based Absorption Models.
Mol Pharm. 2016 Jun 6;13(6):1763-78. doi: 10.1021/acs.molpharmaceut.5b00861. Epub 2016 May 5.
5
In Vitro Assessment of Uptake and Lysosomal Sequestration of Respiratory Drugs in Alveolar Macrophage Cell Line NR8383.
Pharm Res. 2015 Dec;32(12):3937-51. doi: 10.1007/s11095-015-1753-8. Epub 2015 Jul 30.
6
A new physiologically based pharmacokinetic model for the prediction of gastrointestinal drug absorption: translocation model.
Drug Metab Dispos. 2015 Apr;43(4):590-602. doi: 10.1124/dmd.114.060038. Epub 2015 Jan 23.
7
Organic cation transporter/solute carrier family 22a is involved in drug transfer into milk in mice.
J Pharm Sci. 2014 Oct;103(10):3342-8. doi: 10.1002/jps.24138. Epub 2014 Aug 29.
8
Protein abundance of clinically relevant multidrug transporters along the entire length of the human intestine.
Mol Pharm. 2014 Oct 6;11(10):3547-55. doi: 10.1021/mp500330y. Epub 2014 Sep 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验